- Home
- THRD vs CYBN Comparison
THRD vs CYBN Comparison
Compare THRD & CYBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- CYBN
- Stock Information
- Founded
- THRD 2019
- CYBN 2019
- Country
- THRD United States
- CYBN Canada
- Employees
- THRD N/A
- CYBN N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- CYBN Pharmaceuticals and Biotechnology
- Sector
- THRD Health Care
- CYBN Health Care
- Exchange
- THRD Nasdaq
- CYBN Nasdaq
- Market Cap
- THRD 157.7M
- CYBN 153.7M
- IPO Year
- THRD 2022
- CYBN N/A
- Fundamental
- Price
- THRD $3.55
- CYBN $6.31
- Analyst Decision
- THRD Hold
- CYBN Strong Buy
- Analyst Count
- THRD 3
- CYBN 4
- Target Price
- THRD $5.00
- CYBN $86.00
- AVG Volume (30 Days)
- THRD 343.0K
- CYBN 168.0K
- Earning Date
- THRD 05-14-2025
- CYBN 02-11-2025
- Dividend Yield
- THRD N/A
- CYBN N/A
- EPS Growth
- THRD N/A
- CYBN N/A
- EPS
- THRD N/A
- CYBN N/A
- Revenue
- THRD N/A
- CYBN N/A
- Revenue This Year
- THRD N/A
- CYBN N/A
- Revenue Next Year
- THRD N/A
- CYBN N/A
- P/E Ratio
- THRD N/A
- CYBN N/A
- Revenue Growth
- THRD N/A
- CYBN N/A
- 52 Week Low
- THRD $3.18
- CYBN $5.73
- 52 Week High
- THRD $16.94
- CYBN $17.86
- Technical
- Relative Strength Index (RSI)
- THRD 42.90
- CYBN 31.22
- Support Level
- THRD $3.34
- CYBN $7.16
- Resistance Level
- THRD $3.68
- CYBN $7.09
- Average True Range (ATR)
- THRD 0.14
- CYBN 0.37
- MACD
- THRD 0.07
- CYBN -0.06
- Stochastic Oscillator
- THRD 62.86
- CYBN 28.54
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About CYBN Cybin Inc.
Cybin Inc is a biopharmaceutical company involved in creating safe and effective therapeutics for patients to address a multitude of mental health issues. The company is focused on advancing psychedelic-based therapies, delivery mechanisms, novel compounds, and protocols as potential treatments for various psychiatric and neurological conditions.